Effectiveness of Computerized Device New of Visual Motor Simulation Versus Mirror Therapy in Hemiplegic Patients.
- Conditions
- Stroke
- Interventions
- Device: Intensive Visual Simulation 3 (IVS3) deviceDevice: traditional Mirror Therapy (TM)Device: Electroencephalography (EEG)
- Registration Number
- NCT04025411
- Brief Summary
Mirror Therapy (TM) has been shown to be effective in motor rehabilitation of the hemiplegic upper limb, but its implementation in current clinical practice has several difficulties, both from the patient and physiotherapist point of view.
A new computerized Mirror Therapy (TM) device (Intensive Visual Simulation 3 (IVS3), Dessintey) which aims to solve the TM compliance problems and make it more efficient have been developed.
- Detailed Description
The aim of this study is to compare the observance and efficiency of the Intensive Visual Simulation 3 (IVS3) therapy as compared to traditional Mirror Therapy (TM) in a population of hemiplegic stroke patients.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 37
- First ischemic or hemorrhagic stroke for less than one year
- Not having reoffend
- Responsible for an initially complete hemiplegia,
- Upper-limb deficiency with the modified Frenchay Score below 70,
- Not neurological history other than stroke,
- Having signed the written consent
- Affiliated or entitled to a social security scheme
- Patient who have not Magnetic Resonance Images (MRI) of the brain during stroke
- Having complete lesion of the primary motor cortex
- With an addiction to alcohol or drugs
- With psychiatric illness, cognitive impairment, uncontrolled disease / epilepsy, malignancy, severe renal or pulmonary impairment
- History of associated disabling general disease
- With associated cerebellar syndrome
- With clinical involvement of the brainstem
- Pregnancy in progress
- Patients under the protection of justice.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Experimental group Electroencephalography (EEG) Patient with stroke ischemic or hemorrhagic will be included. They will have visual motor simulation with the Intensive Visual Simulation 3 (IVS3) device and electroencephalography (EEG). Control group Electroencephalography (EEG) Patient with stroke ischemic or hemorrhagic will be included. They will have simulation with the traditional Mirror Therapy (TM) and electroencephalography (EEG). Experimental group Intensive Visual Simulation 3 (IVS3) device Patient with stroke ischemic or hemorrhagic will be included. They will have visual motor simulation with the Intensive Visual Simulation 3 (IVS3) device and electroencephalography (EEG). Control group traditional Mirror Therapy (TM) Patient with stroke ischemic or hemorrhagic will be included. They will have simulation with the traditional Mirror Therapy (TM) and electroencephalography (EEG).
- Primary Outcome Measures
Name Time Method Change from baseline Fugl-Meyer motor assessment score at 18 days, at 32 days, and at 60 days Day: 0, 18, 32, 60 Measured by Fugl-Meyer motor assessment score at baseline, at 18 days, at 32 days, and at 60 days.
Fugl-Meyer score assesses the analytical motor skills of the upper limb with minimum score at 0 (hemiplegia) and maximum score at 66 (normal motor performance).
- Secondary Outcome Measures
Name Time Method Change from baseline Barthel index at 18 days, at 32 days, and at 60 days. Day: 0, 18, 32, 60 Measured by Barthel index at baseline, at 18 days, at 32 days, and at 60 days. Barthel index assesses autonomy with minimum score at 0 (total dependence) and maximum score at 100 (complete autonomy).
Change from baseline Abilhand questionnaire at 18 days, at 32 days, and at 60 days. Day: 0, 18, 32, 60 Measured by Abilhand questionnaire at baseline, at 18 days, at 32 days, and at 60 days.
Abilhand questionnaire will allow self-evaluation of the function of the upper limb in daily life with minimum score at 0 (difficulties in daily life) and maximum score at 46 (no difficulties in daily life).Change from baseline modified Frenchay Arm Test score at 18 days, at 32 days, and at 60 days. Day: 0, 18, 32, 60 Measured by Frenchay Arm Test score at baseline, at 18 days, at 32 days, and at 60 days.
Frenchay Arm Test score assesses functional improvement of the activities of the upper limb paretics with minimum score at 0 (total dependence) and maximum score at 100 (complete autonomy).Analysis of brain activity Month: 2 Measured by Electroencephalography (EEG) results.
Trial Locations
- Locations (1)
Chu Saint-Etienne
🇫🇷Saint-Étienne, France